PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the fourth quarter and full year ...
SAN FRANCISCO—In an early look at its annual earnings report, Guardant Health posted revenue gains of 31%—with the $737 million total topping not only Wall Street estimates, but its own ...
Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood test.Please watch the video at Investors.com - The Cell Therapy Market Is ...
We recently compiled a list of the 10 Firms Kick Off Trading Week Soaring. In this article, we are going to take a look at where Guardant Health, Inc. (NASDAQ:GH) stands against the other stocks. Wall ...
Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data ... and elsewhere in its Annual Report on Form 10-K for the year ended December ...
Guardant Health (GH) shares rallied 6.3% in ... is expected to post quarterly loss of $0.51 per share in its upcoming report, which represents a year-over-year change of +67.7%.